Periodic Oxaliplatin Administration in Synergy with PER2-Mediated <i>PCNA</i> Transcription Repression Promotes Chronochemotherapeutic Efficacy of OSCC.

Adv Sci (Weinh) · 2019 · PMC6839751 · PMID 31728273

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

It is worth noting that the apoptosis markers BAX and AIF showed a trend of change in expression level opposite to the DNA adducts repair marker (Figure 3 e).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.